Department of Error : [Erratum zu: Cuzick J, Sestak I, Forbes JF, et al. Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial. Lancet 2020; 395: 117–22]
- The Acknowledgments of this Article have been updated as of Feb 13, 2020.
URN: | urn:nbn:de:hebis:30:3-531402 |
---|---|
DOI: | https://doi.org/10.1016/S0140-6736(20)30323-8 |
ISSN: | 1474-547X |
ISSN: | 0140-6736 |
Pubmed Id: | https://pubmed.ncbi.nlm.nih.gov/32061297 |
Parent Title (English): | The lancet |
Publisher: | Elsevier |
Place of publication: | London [u. a.] |
Document Type: | Article |
Language: | English |
Year of Completion: | 2020 |
Date of first Publication: | 2020/02/15 |
Publishing Institution: | Universitätsbibliothek Johann Christian Senckenberg |
Release Date: | 2020/03/18 |
Volume: | 395 |
Issue: | 10233 |
Page Number: | 1 |
First Page: | 496 |
Last Page: | 496 |
Note: | Copyright: © 2020 The Author(s). Published by Elsevier Ltd. User License: Creative Commons Attribution (CC BY 4.0) |
Note: | Ursprünglicher Artikel erschienen in: The lancet, 395.2020, Nr. 10218, S. 117-122, doi:10.1016/S0140-6736(19)32955-1 |
HeBIS-PPN: | 463783298 |
Institutes: | Medizin / Medizin |
Dewey Decimal Classification: | 6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit |
Sammlungen: | Universitätspublikationen |
Licence (German): | Creative Commons - Namensnennung 4.0 |